Company news
MiNK Therapeutics, Inc. news in 2022
MiNK Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.
MiNK Presents Clinical Data at SITC 2022 Showcasing iNKT Cell Therapy Pipeline
November 9, 2022
MiNK Therapeutics Reports Corporate Update and Third Quarter 2022 Financial Results
November 2, 2022
MiNK Therapeutics to Report Third Quarter 2022 Financial Results and Business Update
October 19, 2022
MiNK Therapeutics to Host R&D Event November 10, 2022
October 4, 2022
MiNK Selected for Five Presentations at Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
October 4, 2022
MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results
August 8, 2022
MiNK Therapeutics to Report Second Quarter 2022 Financial Results and Business Update
July 26, 2022
MiNK Therapeutics Corporate Update and First Quarter 2022 Financial Report
May 9, 2022
MiNK Therapeutics to Report First Quarter 2022 Financial Results and Business Update
April 26, 2022
MiNK Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
March 17, 2022
MiNK Therapeutics Announces Patients Dosed with AgenT-797 iNKT Cell Therapy in Solid Tumor Cancers
March 2, 2022
Calls in 2022
Decks in 2022
- Investor Day (November 2022)
Investor day · 92 slides · Nov 10, 2022